Purinergic P2X


Journal

American journal of physiology. Renal physiology
ISSN: 1522-1466
Titre abrégé: Am J Physiol Renal Physiol
Pays: United States
ID NLM: 100901990

Informations de publication

Date de publication:
01 06 2020
Historique:
pubmed: 21 4 2020
medline: 8 10 2020
entrez: 21 4 2020
Statut: ppublish

Résumé

In ANG II-dependent hypertension, ANG II activates ANG II type 1 receptors (AT

Identifiants

pubmed: 32308022
doi: 10.1152/ajprenal.00602.2019
pmc: PMC7311710
doi:

Substances chimiques

Angiotensin II Type 1 Receptor Blockers 0
Antihypertensive Agents 0
P2rx7 protein, rat 0
Purinergic P2X Receptor Antagonists 0
Receptor, Angiotensin, Type 1 0
Receptors, Purinergic P2X1 0
Receptors, Purinergic P2X7 0
Angiotensin II 11128-99-7

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

F1400-F1408

Subventions

Organisme : NIGMS NIH HHS
ID : P30 GM103337
Pays : United States
Organisme : HHS | NIH | National Institute of General Medical Sciences (NIGMS)
ID : CoBRE P30GM103337
Pays : International

Références

Kidney Int. 2015 Nov;88(5):1079-87
pubmed: 26108066
Am J Physiol Renal Physiol. 2014 Mar 15;306(6):F608-18
pubmed: 24431199
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4322-7
pubmed: 12655045
Hypertens Res. 2004 Nov;27(11):791-804
pubmed: 15824461
Am J Hypertens. 2000 Jul;13(7):810-8
pubmed: 10933574
J Pharmacol Exp Ther. 1993 Apr;265(1):334-8
pubmed: 8474016
Am J Physiol Renal Physiol. 2012 Sep;303(5):F775-82
pubmed: 22674024
Kidney Int. 2004 Jul;66(1):157-66
pubmed: 15200422
Am J Physiol Renal Physiol. 2008 Jan;294(1):F161-9
pubmed: 17989111
Am J Physiol. 1998 Apr;274(4):F718-27
pubmed: 9575896
Hypertension. 2011 Apr;57(4):780-7
pubmed: 21321307
Am J Physiol Renal Physiol. 2011 Jun;300(6):F1301-9
pubmed: 21367914
J Neurosci. 2004 Mar 31;24(13):3413-20
pubmed: 15056721
Curr Med Chem. 2015;22(7):915-28
pubmed: 25515515
Am J Physiol Renal Physiol. 2002 Feb;282(2):F245-55
pubmed: 11788438
J Am Soc Nephrol. 1999 Jan;10 Suppl 11:S178-83
pubmed: 9892160
J Cell Sci. 2011 Oct 15;124(Pt 20):3477-83
pubmed: 22010198
J Clin Invest. 2003 Dec;112(12):1895-905
pubmed: 14679185
Acta Physiol Scand. 2004 Aug;181(4):445-53
pubmed: 15283757
Am J Physiol Renal Physiol. 2019 Nov 1;317(5):F1132-F1141
pubmed: 31432708
Am J Physiol Renal Physiol. 2012 Oct 15;303(8):F1207-15
pubmed: 22859404
J Am Soc Nephrol. 1997 Apr;8(4):535-42
pubmed: 10495782
Circ Res. 2000 Mar 31;86(6):656-62
pubmed: 10747001
Am J Physiol Renal Physiol. 2008 Jan;294(1):F212-9
pubmed: 17977908
Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1477-H1485
pubmed: 30141983
Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H772-7
pubmed: 16214849
Front Cell Neurosci. 2014 May 09;8:125
pubmed: 24847210
Hypertens Res. 2012 Feb;35(2):173-9
pubmed: 21918525
Br J Pharmacol. 2009 Aug;157(7):1203-14
pubmed: 19558545
J Med Chem. 2006 Jun 15;49(12):3659-66
pubmed: 16759108
Am J Physiol. 1997 Jul;273(1 Pt 2):F170-7
pubmed: 9249605
Curr Opin Nephrol Hypertens. 2009 Mar;18(2):138-43
pubmed: 19430334
Hypertension. 1996 Oct;28(4):669-77
pubmed: 8843896
EMBO J. 2011 May 03;30(12):2350-63
pubmed: 21540834
Eur J Pharmacol. 1996 Jun 13;306(1-3):139-52
pubmed: 8813626
Am J Physiol Renal Physiol. 2018 Jan 1;314(1):F70-F80
pubmed: 28978531
Eur J Med Chem. 2004 Apr;39(4):345-57
pubmed: 15072843
J Clin Invest. 1976 Feb;57(2):419-34
pubmed: 1254727
Am J Physiol. 1996 Nov;271(5 Pt 2):F1077-85
pubmed: 8946003
Front Cell Neurosci. 2013 Nov 25;7:226
pubmed: 24324400
Curr Opin Nephrol Hypertens. 2014 Jan;23(1):38-45
pubmed: 24275770
J Am Soc Nephrol. 2015 Dec;26(12):2953-62
pubmed: 25855778
Cells Tissues Organs. 2003;175(2):105-17
pubmed: 14605489
J Hypertens. 2003 Feb;21(2):353-60
pubmed: 12569266
Am J Physiol. 1998 May;274(5):F940-5
pubmed: 9612332
J Am Heart Assoc. 2017 Sep 12;6(9):
pubmed: 28899893
Am J Physiol Renal Physiol. 2017 Jul 1;313(1):F9-F19
pubmed: 28404593
Am J Physiol Renal Physiol. 2009 Mar;296(3):F590-7
pubmed: 19129253
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17985-90
pubmed: 17090678

Auteurs

Supaporn Kulthinee (S)

Department of Physiology and Hypertension and Renal Center of Excellence, Tulane University Health Science Center, New Orleans, Louisiana.
Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, Thailand.

Weijian Shao (W)

Department of Physiology and Hypertension and Renal Center of Excellence, Tulane University Health Science Center, New Orleans, Louisiana.

Martha Franco (M)

Department of Cardio-Renal Physiopathology, Instituto Nacional de Cardiología "Ignacio Chávez," México City, México.

L Gabriel Navar (LG)

Department of Physiology and Hypertension and Renal Center of Excellence, Tulane University Health Science Center, New Orleans, Louisiana.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH